Capital Fund Management S.A. Biogen Inc. Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $2.78 Million - $3.48 Million	-14,700 Reduced 18.26%	65,800 $12.8 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $1.43 Million - $1.78 Million	-7,500 Reduced 8.52%	80,500 $18.7 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $614,858 - $776,358	2,900 Added 3.41%	88,000 $19 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $14 Million - $16.9 Million	62,900 Added 283.33%	85,100 $22 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $5.62 Million - $6.35 Million	22,200 New	22,200 $5.71 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $3.03 Million - $3.45 Million	11,800 New	11,800 $3.28 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4.56 Million - $6.28 Million	-23,400 Reduced 60.15%	15,500 $4.14 Billion
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $2.25 Million - $2.68 Million	-12,000 Reduced 23.58%	38,900 $7.93 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $7.52 Million - $9.47 Million	38,800 Added 320.66%	50,900 $10.7 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $2.98 Million - $3.79 Million	11,100 Added 1110.0%	12,100 $3.83 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $2.95 Million - $4.07 Million	-13,400 Reduced 93.06%	1,000 $297,000
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $1.36 Million - $1.5 Million	-6,200 Reduced 30.1%	14,400 $3.37 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $6.91 Million - $10.8 Million	-31,900 Reduced 60.76%	20,600 $4.87 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $17.4 Million - $22 Million	-62,400 Reduced 54.31%	52,500 $15.8 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $20.6 Million - $27 Million	-70,300 Reduced 37.96%	114,900 $40.6 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $6.7 Million - $7.98 Million	26,000 Added 16.33%	185,200 $53.8 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $30.8 Million - $43.5 Million	118,300 Added 289.24%	159,200 $43.6 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $7.94 Million - $8.89 Million	25,800 Added 170.86%	40,900 $13 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $4.25 Million - $4.98 Million	15,100	15,100 $4.73 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account